Market share of insulin and biosimilars in India 2020, by foreign and domestic firms

As of 2020, 75 percent of India’s insulin market is controlled by multinational corporations. The biosimilars market, on the other hand, is overwhelmingly controlled by domestic pharmaceutical companies.

…. more: Statista.com (Quelle/Source)